ATP8B1FIC1related

ATP8B1FIC1 related refers to diseases caused by biallelic variants in the ATP8B1 gene, which encodes the FIC1 protein. FIC1 is a canalicular membrane P4-ATPase that helps maintain phospholipid asymmetry in hepatocyte membranes, a process important for normal bile formation and protection of cholangiocytes from bile salts. Proper function of ATP8B1 is essential for stable canalicular membranes in the liver and for related tissues.

Genetics and mechanism: Inheritance is typically autosomal recessive, requiring pathogenic variants from both parents. Mutations disrupt FIC1 function, leading to impaired bile secretion and chronic cholestasis. The spectrum of disease includes progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis type 1 (BRIC1). PFIC1 usually presents in infancy or early childhood with persistent cholestasis, pruritus, jaundice, and growth delay, and may progress to cirrhosis. BRIC1 is characterized by intermittent cholestatic episodes with periods of normal liver function between episodes.

Clinical features: Common findings include persistent or intermittent cholestasis, pruritus, elevated bile acids, and variable elevations of alkaline phosphatase and bilirubin. Growth may be affected in PFIC1, and hepatosplenomegaly can occur. Extrahepatic involvement is possible but less prominent.

Diagnosis: Suspected in infants or children with cholestasis of unclear etiology and a compatible family history. Genetic testing revealing biallelic ATP8B1 variants confirms the diagnosis. Liver biopsy may show cholestasis with relatively normal gamma-glutamyltransferase levels in PFIC1. Evaluation includes assessment of liver function, nutritional status, and exclusion of other causes of cholestasis.

Management and prognosis: Treatment is supportive and symptom-directed, including pruritus management and nutritional support. Ursodeoxycholic acid is used variably; rifampin can help pruritus. In selected PFIC1 cases, surgical biliary diversion or liver transplantation may be considered. Ongoing research aims to clarify genotype–phenotype correlations and develop targeted therapies.